Prof. Dr. GÜLNUR GÜLER

Makaleler 52

1. Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers

Irkkan C., Balci S., Tezel G. G., Akinci B., Yalcin B., GÜLER G.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , cilt.25, sa.9, ss.609-614, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Development and formulation of floating tablet formulation containing rosiglitazone maleate using Artificial Neural Network

Güler G., EROĞLU H., ÖNER L.

Journal of Drug Delivery Science and Technology , cilt.39, ss.385-397, 2017 (SCI-Expanded, Scopus)

3. Metastasis of prostate adenocarcinoma to the frontal and ethmoid sinus

Akdemir F., Aldemir M., Cakar H., GÜLER G.

TURKISH JOURNAL OF UROLOGY , cilt.42, sa.4, ss.299-302, 2016 (ESCI, Scopus, TRDizin)

4. Skin punch biopsy sectioning: before or after tissue processing?

SÜNGÜ N., Yavuz S., Marali S., Balci S., KILIÇARSLAN A., ALTUNKAYA C., et al.

JOURNAL OF CUTANEOUS PATHOLOGY , cilt.43, sa.11, ss.984-988, 2016 (SCI-Expanded, Scopus)

5. Thyroid FNAC containing hurthle cells and hurthle-like cells: A study of 128 cases

Yazgan A., Balci S., Dincer N., Ersoy P. E., TÜZÜN D., ERSOY R., et al.

JOURNAL OF CYTOLOGY , cilt.33, sa.4, ss.214-219, 2016 (SCI-Expanded, Scopus)

6. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer

Raza U., Saatci O., Uhlmann S., Ansari S. A., Eyupoglu E., Yurdusev E., et al.

ONCOTARGET , cilt.7, sa.31, ss.49859-49877, 2016 (SCI-Expanded, Scopus)

7. The correlation of sodium iodide symporter and BRAF(V600E) mutation in classical variant papillary thyroid carcinoma

Yazgan A., Yildirim N., Gozalan A., Gumustas S., KILIÇARSLAN A., Balci S., et al.

ANNALS OF DIAGNOSTIC PATHOLOGY , cilt.22, ss.58-62, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Retrospective analysis of oncogenic human papilloma virus and. Epstein-Barr virus prevalence in Turkish nasopharyngeal cancer patients

Dogan H. T., Kilicarslan A., Dogan M., Sungu N., Tezel G. G., GÜLER G.

PATHOLOGY RESEARCH AND PRACTICE , cilt.212, sa.11, ss.1021-1026, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Molecular Features of Follicular Variant Papillary Carcinoma of Thyroid: Comparison of Areas With or Without Classical Nuclear Features

Guney G., Tezel G. G., KÖSEMEHMETOĞLU K., Yilmaz E., Balci S., Ersoy R., et al.

ENDOCRINE PATHOLOGY , cilt.25, sa.3, ss.241-247, 2014 (SCI-Expanded, Scopus)

10. The use of Platelet Rich Fibrin Membrane in Rabbit Conjunctival Tissue Damage

Can M. E., Cakmak H. B., Toklu Y., Can G. D., Unverdi H., Hucemenoglu S., et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE , cilt.55, sa.13, 2014 (SCI-Expanded, Scopus)

11. microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers

Gasparini P., Cascione L., Fassan M., Lovat F., Guler G., Balci S., et al.

ONCOTARGET , cilt.5, sa.5, ss.1174-1184, 2014 (SCI-Expanded, Scopus)

12. Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options

Gasparini P., Fassan M., Cascione L., GÜLER G., Balci S., Irkkan C., et al.

PLOS ONE , cilt.9, sa.2, 2014 (SCI-Expanded, Scopus)

13. Carcinomas with Apocrine Differentiation: Comparison of Clinicopathologic Features with Invasive Breast Carcinoma of No Special Type (NST) in Turkish Patients

Kiyici H., GÜLER G., Altundag K.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.2, ss.118-122, 2014 (SCI-Expanded, Scopus, TRDizin)

14. Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy

OZCAN M. F., Dizdar O., DINCER N., BALCI S., Guler G., GOK B., et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , cilt.31, sa.8, ss.1709-1715, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary

DEDE D. S., GUMUSKAYA B., Guler G., ONAT D., ALTUNDAG K., ÖZIŞIK Y. Y.

JOURNAL OF BUON , cilt.18, sa.2, ss.366-371, 2013 (SCI-Expanded, Scopus)

16. Screening for and Genotyping of Human Papilloma Virus in Prostitutes

KETEN A., KETEN D., BALSEVEN ODABAŞI A., TEZEL G. G., GÜLER G., TÜMER A. R.

Türkiye Klinikleri Tıp Bilimleri Dergisi , cilt.33, sa.3, ss.601-606, 2013 (Scopus)

17. Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel

Dede D. S., Gumuskaya B., Guler G., Onat D., Altundag K., Ozisik Y.

JOURNAL OF BUON , cilt.18, sa.1, ss.57-63, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Lymphatic and Capillary Invasion Patterns in Triple Negative Breast Cancer

Yaman S., Gumuskaya B., Ozkan C., AKSOY S., GÜLER G., Altundag K.

AMERICAN SURGEON , cilt.78, sa.11, ss.1238-1242, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Does Androgen Receptor Have a Prognostic Role in Patients with Estrogen/Progesterone-Negative and c-erbB-2-Positive Breast Cancer?

Arslan C., Isik M., GÜLER G., Kulac I., Solak M., Turker B., et al.

AMERICAN SURGEON , cilt.78, sa.9, ss.992-999, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Stem cell-related markers in primary breast cancers and associated metastatic lesions

Guler G., Balci S., Costinean S., UŞŞAKLI Ç., Irkkan C., Suren D., et al.

MODERN PATHOLOGY , cilt.25, sa.7, ss.949-955, 2012 (SCI-Expanded, Scopus)

21. ERCC1 expression in triple negative breast cancer

Ozkan C., Gumuskaya B., YAMAN S., AKSOY S., Guler G., Altundag K.

JOURNAL OF BUON , cilt.17, sa.2, ss.271-276, 2012 (SCI-Expanded, Scopus)

22. EGFR Expression and Gene Copy Number in Malignant Pleural Mesothelioma fin Turkey

ONDER S., GULER G., Emri S., FIRAT P.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.3, ss.181-186, 2012 (SCI-Expanded, Scopus, TRDizin)

23. Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features

GÜLER G., Himmetoglu C., Jimenez R. E., Geyer S. M., Wang W. P., Costinean S., et al.

BREAST CANCER RESEARCH AND TREATMENT , cilt.129, sa.2, ss.421-432, 2011 (SCI-Expanded, Scopus)

24. Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer

Sari E., Guler G., HAYRAN K. M., Gullu İ. H., Altundag K., Ozisik Y.

MEDICAL ONCOLOGY , cilt.28, sa.1, ss.57-63, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. EGFR expression and gene copy number in triple-negative breast carcinoma

Gumuskaya B., Alper M., Hucumenoglu S., Altundag K., ÜNER A., GÜLER G.

CANCER GENETICS AND CYTOGENETICS , cilt.203, sa.2, ss.222-229, 2010 (SCI-Expanded, Scopus)

26. Papillary apocrine metaplasia and columnar cell lesion with atypia: is there a shared common pathway?

KÖSEMEHMETOĞLU K., Guler G.

ANNALS OF DIAGNOSTIC PATHOLOGY , cilt.14, sa.6, ss.425-431, 2010 (SCI-Expanded, Scopus)

27. The changes of molecular markers with neoadjuvant dose-dense doxorubicin hydrochloride, cyclophosphamide, and paclitaxel chemotherapy regimen

Dede D. S., Gumuskaya B., Guler G., Onat D. A., Altundag K., Ozisik Y. Y.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.15, 2010 (SCI-Expanded, Scopus)

28. Lymphatic and vascular invasion patterns in triple-negative breast cancer.

Yaman S., Gumuskaya B., Ozkan C., Aksoy S., Guler G., Altundag M. K.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.15, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Expression of ERCC1 in triple-negative breast cancer

Ozkan C., Gumuskaya B., Yaman S., Aksoy S., Guler G., Altundag M. K.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.15, 2010 (SCI-Expanded, Scopus)

30. FHIT Gene Sequence Variants and Reduced Fhit Protein Expression in Glioblastoma Multiforme

ÇEÇENER G., TUNCA B., EGELİ Ü., BEKAR A., GÜLER G., TOLUNAY Ş., et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY , cilt.30, sa.2, ss.301-307, 2010 (SCI-Expanded, Scopus)

31. Investigation of MMAC/PTEN Gene Mutations and Protein Expression in Low Grade Gliomas

ÇEÇENER G., TUNCA B., EGELİ Ü., BEKAR A., GÜLER G., VATAN Ö., et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY , cilt.29, sa.5, ss.733-738, 2009 (SCI-Expanded, Scopus)

32. Fragile Histidine Triad Protein, WW Domain-containing Oxidoreductase Protein Wwox, and Activator Protein 2 gamma Expression Levels Correlate With Basal Phenotype in Breast Cancer

Guler G., Huebner K., Himmetoglu C., Jimenez R. E., Costinean S., Volinia S., et al.

CANCER , cilt.115, sa.4, ss.899-908, 2009 (SCI-Expanded, Scopus)

33. RET finger protein expression in invasive breast carcinoma: Relationship between RFP and ErbB2 expression

Tezel G. G., ÜNER A., Yildiz I., GÜLER G., Takahashi M.

PATHOLOGY RESEARCH AND PRACTICE , cilt.205, sa.6, ss.403-408, 2009 (SCI-Expanded, Scopus)

34. Primary orbital endodermal sinus tumor (yolk sac tumor)

KIRATLI H., Balci K. E., GÜLER G.

JOURNAL OF AAPOS , cilt.12, sa.6, ss.623-625, 2008 (SCI-Expanded, Scopus)

35. Fhit and Wwox expression in mucoepidermoid and adenoid cystic carcinomas

Dincer N., Tezel G. G., Himmetoglu C., Huebner K., GÜLER G., Sungur A.

VIRCHOWS ARCHIV , cilt.452, 2008 (SCI-Expanded, Scopus)

36. Atypical teratoid/rhabdoid tumors: Imaging gindings of two cases and review of the literature

Tez S., Koktener A., GÜLER G., Ozisik P.

TURKISH NEUROSURGERY , cilt.18, sa.1, ss.30-34, 2008 (SCI-Expanded, Scopus)

37. Investigation of mutations and expression of the FHIT gene in Turkish patients with brain metastases derived from non-small cell lung cancer

BEKAR A., Cecener G., TUNCA B., GÜLER G., EGELİ Ü., TOLUNAY Ş.

TUMORI J , cilt.93, sa.6, ss.604-607, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.104, sa.40, ss.15805-15810, 2007 (SCI-Expanded, Scopus)

39. Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers

Elsakov P., Foretova L., Goetz P., de Groot J. W. B., van der Graaf W. T. A., GÜLER G., et al.

HEREDITARY CANCER IN CLINICAL PRACTICE , cilt.5, sa.3, ss.119-143, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. "Complex apocrine metaplasia" and "atypical columnar cell lesion" are they really so distant?

Kosemehmetoglu K., Guler G.

VIRCHOWS ARCHIV , cilt.451, sa.2, ss.207, 2007 (SCI-Expanded, Scopus)

41. Expression levels of FHIT and WWOX correlate with Her-2 protein overexpression and gene amplification in breast cancer

Guler G., Tezel G. G., Yildiz I., ÜNER A., Huebner K.

VIRCHOWS ARCHIV , cilt.451, sa.2, ss.206, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Roles of FHIT and WWOX fragile genes in cancer

Iliopoulos D., Guler G., Han S., Druck T., Ottey M., McCorkell K., et al.

CANCER LETTERS , cilt.232, sa.1, ss.27-36, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Concordant loss of fragile gene expression early in breast cancer development

Guler G., ÜNER A., Guler N., Han S., Iliopoulos D., McCue P., et al.

PATHOLOGY INTERNATIONAL , cilt.55, sa.8, ss.471-478, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. The effects of selective nitric oxide synthase blocker on survival, mesenteric blood flow and multiple organ failure induced by zymosan

Tanriverdi P., Yuksel B., Rasa K., Guler G., Iskit A., Guc M., et al.

JOURNAL OF SURGICAL RESEARCH , cilt.124, sa.1, ss.67-73, 2005 (SCI-Expanded, Scopus)

45. Expression of hepatocyte growth factor/scatter factor receptor in IUGR fetuses' placentas: An immunohistochemical analysis

Baykal C., Guler G., Al A., Tulunay G., Ozer S., Yencilek R., et al.

FETAL DIAGNOSIS AND THERAPY , cilt.20, sa.4, ss.249-253, 2005 (SCI-Expanded, Scopus)

46. High-grade neuroendocrine carcinoma of the cervix - A case report

Baykal C., Al A., Tulunay G., Bulbul D., Guler G., Ozer S., et al.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION , cilt.59, sa.4, ss.207-211, 2005 (SCI-Expanded, Scopus)

47. CpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumors

Han S., Iliopoulos D., Druck T., Guler G., Grubbs C., Pereira M., et al.

ONCOGENE , cilt.23, sa.22, ss.3990-3998, 2004 (SCI-Expanded, Scopus)

48. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma - Correlations with clinical features

Guler G., ÜNER A., Guler N., Han S., Iliopoulos D., Hauck W., et al.

CANCER , cilt.100, sa.8, ss.1605-1614, 2004 (SCI-Expanded, Scopus)

49. Is visual loss due to giant cell arteritis reversible?

Calguneri M., Cobankara V., Ozathi D., Guler G., Apras S., Pay S., et al.

YONSEI MEDICAL JOURNAL , cilt.44, sa.1, ss.155-158, 2003 (SCI-Expanded, Scopus)

50. Role of mast cells and angiogenic growth factors in the genesis of capillary hemangioblastoma

Soylemezoglu F., Guler G., Inci S.

BRAIN PATHOLOGY , cilt.10, sa.4, ss.745, 2000 (SCI-Expanded, Scopus)

51. Tumor metastasis to an oncocytoma

Altinok G., Guler G., Sahin A.

SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY , cilt.33, sa.6, ss.416-417, 1999 (SCI-Expanded, Scopus)

52. Mohr syndrome in two sisters: Prenatal diagnosis in a 22-week-old fetus with post-mortem findings in both

Balci S., Guler G., Kale G., Soylemezoglu F., Besim A.

PRENATAL DIAGNOSIS , cilt.19, sa.9, ss.827-831, 1999 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 15

1. Imaging Armamentarium of Hyperparathyroidism; New Player FCH PET-CT-US

TUNCEL M., Kaya G., Caglar M., Kaynaroglu V., CENNET Ö., ÜNLÜTÜRK U., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, (Özet Bildiri)

2. Clinical histological and immunophenotypical features of high grade adenosquamous aarcinomas of the breast

Abdullazade S., Ekmekçi S., Baran F., KÖSEMEHMETOĞLU K., GÜLER G.

XXXI International Congress of the International Academy of Pathology and the 28th Congress of the European Society of Pathology, 25 - 29 Eylül 2016, (Özet Bildiri)

3. Memenin Osteosarkomu

ÜNER H., ATEŞ D., KÖSEMEHMETOĞLU K., GÜLER G.

23. Ulusal Patoloji Kongresi, Türkiye, 6 - 10 Kasım 2013

4. Correlation of Her2 Protein Expression and Gene Amplification between Endoscopic and Surgical Specimens of Gastric Cancer

Irkkan C., Balci S., Tezel G. G., Akinci B., Yalcin B., Guler G.

102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Maryland, Amerika Birleşik Devletleri, 2 - 08 Mart 2013, cilt.93, (Özet Bildiri) Sürdürülebilir Kalkınma

5. The Incidence of EBV and Her2 Positivity in Gastric Cancers

Irkkan C., Balci S., Tezel G. G., Akinci B., Yalcin B., Guler G.

102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Maryland, Amerika Birleşik Devletleri, 2 - 08 Mart 2013, cilt.26, (Özet Bildiri) Sürdürülebilir Kalkınma

6. Gastrointestinal Stromal Tumor Metastatic to Bone: Clinicopathological and Molecular Features of 29 Cases, Including 8 Previously Unreported Cases

Kosemehmetoglu K., Kaygusuz G., Fritchie K., Aydin O., Yapicier O., Coskun O., et al.

102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Maryland, Amerika Birleşik Devletleri, 2 - 08 Mart 2013, cilt.93, (Özet Bildiri)

7. Comparison of Single Versus 2 Fractions of Radiosurgery for Brain Metastases: A Prospective Randomized Study

Cengiz M., Ozyigit G., Guney Y., Mayadagli A., Guler G., Kocak M., et al.

54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Massachusetts, Amerika Birleşik Devletleri, 28 - 31 Ekim 2012, cilt.84, (Özet Bildiri)

8. K-ras Mutations in Triple Negative Breast Carcinomas

Kulac I., Balci S., Altundag K., Baykal A., Tezel G. G., Guler G.

101st Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Vancouver, Kanada, 17 - 23 Mart 2012, cilt.25, (Özet Bildiri)

9. Molecular Features of Follicular Variant Papillary Carcinoma of Thyroid: Comparison of Areas with or without Classical Nuclear Features

Guney G., Tezel G. G., Kosemehmetoglu K., Yilmaz E., Ersoy R., Cakir B., et al.

101st Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Vancouver, Kanada, 17 - 23 Mart 2012, cilt.92, (Özet Bildiri)

10. Folliküler varyant tiroid papiller karsinomunun moleküler özellikleri Klasik nükleer özellik içeren ve içermeyen alanların karşılaştırılması

GÜNEY G., KÖSEMEHMETOĞLU K., GÜLER TEZEL Y. G., ERSOY R., ÇAKIR B., YILMAZ E., et al.

21. Ulusal Patoloji Kongresi, Türkiye, 16 - 20 Kasım 2011, (Özet Bildiri)

11. WWOX Gene Methylation, WWOX and FHIT Protein Expression in Primary Breast Tumors and Breast Parenchymal Tissues and Their Relationship to Prognostic and Epidemiological Data

Ussakli C. H., Huebner K., Guler G.

100th Annual Meeting of the United States and Canadian-Academy-of-Pathology, San-Antonio, Kuzey Mariana Adaları, 26 Şubat - 04 Mart 2011, cilt.91, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

1952

H-İndeks (WoS)

Atıf (Scopus)

336

H-İndeks (Scopus)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler